The European Commission is expected to take a decision on the advance purchase of 300 million doses of the Covid-19 vaccine developed by Pfizer and BioNTech on Wednesday, 11 November, during the college’s weekly meeting. If confirmed, this decision would be followed by an official signature in the coming days.
European Commission spokesman Eric Mamer affirmed that this event is independent of the good Phase III clinical trial results communicated by the German-American alliance the...